| Size & multiples | |||
| Market Cap | $11.28B | Enterprise Value | $11.27B |
| P/E (TTM) | 156.67× | PEG (trailing) | — |
| P/S | 9.32× | P/FCF | 41.85× |
| EV/EBITDA | 44.37× | EV/EBIT | 73.33× |
| EV/Sales | 9.31× | EV/FCF | 41.82× |
| FCF Yield | 2.39% | Buyback Yield | 0.89% |
| Owner Earnings (TTM) | $184.6M | Owner Earnings Yield | 1.64% |
| Shareholder Yield | 1.33% | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.26 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 10.29% |
| After-tax Cost of Debt | 3.61% | Synthetic credit rating | AAA |
| Cost of Debt · embedded (pre-tax) | 4.84% | Cost of Debt · marginal (synthetic) | 4.40% |
| WACC | 10.17% | ROIC | 3.51% |
| EVA Spread (ROIC−WACC) | −6.66% | EVA | -$140.0M |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $0.46 · revenue TTM $1.21B · FCF TTM $269.6M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E, EV/EBITDA
P/E 95th · EV/EBITDA 89th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 156.7x | 24.4x | 13.0x–39.3x | 95 ↑rich |
| EV/EBITDA | 52.5x | 15.1x | 9.8x–24.4x | 89 ↑rich |
| FCF Yield | 2.3% | -7.8% | -34.7%–1.4% | 78 ↑strong |
| Dividend Yield | 0.4% | 1.1% | 0.2%–2.4% | 30 ↓weak |
| Net Margin | 6.0% | -21.2% | -325.3%–7.2% | 73 ↑strong |
| Operating Margin | 8.4% | -34.5% | -552.0%–8.0% | 75 ↑strong |
